Skip to main content

Risk for Ovarian Cancer Increased for Women With Endometriosis

Medically reviewed by Carmen Pope, BPharm. Last updated on July 19, 2024.

By Elana Gotkine HealthDay Reporter

THURSDAY, July 18, 2024 -- Women with endometriosis have an increased risk of ovarian cancer, with the highest risk seen for women with deep infiltrating endometriosis and/or ovarian endometriomas, according to a study published online July 17 in the Journal of the American Medical Association.

Mollie E. Barnard, Sc.D., from the University of Utah in Salt Lake City, and colleagues examined the associations of endometriosis subtypes with te incidence of ovarian cancer in a population-based cohort study using data from the Utah Population Database. A total of 78,893 women with endometriosis were matched in a 1:5 ratio to women without endometriosis.

The age at first endometriosis diagnosis was 36 years. Overall, 597 women had ovarian cancer. The researchers found that the risk for ovarian cancer was higher for women with versus those without endometriosis (adjusted hazard ratio, 4.20), and the risk for type I ovarian cancer was especially high (adjusted hazard ratio, 7.48). For all ovarian cancers, type I ovarian cancer, and type II ovarian cancer, the risk was highest for women with deep infiltrating endometriosis and/or ovarian endometriomas (adjusted hazard ratios, 0.66, 18.96, and 3.72, respectively).

"Studies that can better characterize the biology underlying these associations are urgently needed to guide improved ovarian cancer screening and prevention strategies among women with severe endometriosis, with or without other important ovarian cancer risk factors," the authors write.

One author received fees from Epi Excellence, and a second received fees from Epidemiologic Research & Methods.

Abstract/Full Text (subscription or payment may be required)

Editorial (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted July 2024

Read this next

Premenopausal Bilateral Oophorectomy Before Age 40 Affects Brain White Matter

TUESDAY, July 9, 2024 -- Women who undergo premenopausal bilateral oophorectomy (PBO) before age 40 years have reduced brain white matter integrity in later life, according to a...

ENDO: Early Menopause Tied to Heightened Risk for Breast, Ovarian Cancer

TUESDAY, June 11, 2024 -- Women with early menopause have a two times greater risk for breast cancer and a nearly four times higher risk for ovarian cancer, according to a study...

ASCO: Conjugated Equine Estrogen May Increase Risk for Ovarian Cancer

TUESDAY, May 28, 2024 -- Conjugated equine estrogen (CEE) taken alone for menopause may increase the risk for developing and dying from ovarian cancer, according to a study...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.